Found: 1
Select item for more details and to access through your institution.
A phase 1, randomized, double‐blind, placebo‐controlled trial investigating the pharmacokinetics, pharmacodynamics, safety and tolerability of oral semaglutide in healthy Chinese subjects.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3068, doi. 10.1111/dom.15624
- By:
- Publication type:
- Article